Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Federal Trade Commission
Healthtrust
Merck
Accenture
Chinese Patent Office
Cantor Fitzgerald
AstraZeneca

Generated: May 20, 2018

DrugPatentWatch Database Preview

Rifapentine - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for rifapentine and what is the scope of rifapentine freedom to operate?

Rifapentine
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.
Summary for rifapentine
Pharmacology for rifapentine
Ingredient-typeRifamycins
Drug ClassRifamycin Antimycobacterial
Synonyms for rifapentine
(2R,16S,17R,18R,19R,20S,21S,22S,23S)-8-{[(4-CYCLOPENTYLPIPERAZIN-1-YL)IMINO]METHYL}-5,6,9,17,19-PENTAHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-1,11-DIOXO-1,2-DIHYDRO-2,7-(EPOXYPENTADECA[1,11,13]TRIENOIMINO)NAPHTHO[2,1
(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-8-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoi
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5
[[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-pentahydroxy-methoxy-heptamethyl-dioxo-[?]yl] acetate
1279038-35-5
3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)-rifamyci;3-(4-cyclopentyl-1-piperazinyl)iminomethylrifamycinsv
3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)rifamycin
3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)rifamycin SV
3-(4-Cyclopentyl-1-piperazinyl)iminomethylrifamycin SV
3-(N-(4-Cyclopentyl-1-piperazinyl)formimidoyl)rifamycin
3-[[(4-cyclopentyl-1-piperazinyl)-imino]methyl]rifamycin/rifapentine hydrochloride
3-[N-(4-Cyclopentyl-1-piperazinyl)formimidoyl]rifamycin
3{[(4-cyclopentyl-1-piperazinyl)imino]methyl}rifamycin
379R655
61379-65-5
71950-35-1
773848-08-1
AB01209744_04
AB01209744-01
AB01209744-03
AC-729
AK326142
AKOS015961203
AKOS024255723
Ambap127923-87-9
AN-15578
AN-32615
Antibiotic DL 473IT
BC206226
BIDD:GT0669
BRD-K55889443-001-01-8
C08059
C47H64N4O12
CAS-61379-65-5
CCG-101040
CCG-220467
CHEBI:45304
CHEMBL1660
CHEMBL3190412
CPD000466332
CPD001906779
CS-2258
Cyclopentyl rifampin
Cyclopentylrifampicin
D00879
D02AON
D0G9IU
DB01201
DL 473
DL 473-IT
DL-4-73
DL-473
DL473
DRG-0283
DSSTox_CID_21115
DSSTox_GSID_41115
DSSTox_RID_79627
DTXSID8041115
EBD14154
EINECS 262-743-9
HMS2051D16
HMS2231H16
HMS3259L06
HY-B0269
I14-0963
J90035
KS-00000H16
KS-1409
KTC 1
LS-143825
M000473
MDL 473
MDL-473
MDL473
MFCD00866806
MLS000759441
MLS001424209
MLS003882561
MolPort-006-132-325
MolPort-035-395-832
MolPort-044-561-689
MolPort-044-723-794
NC00290
NC00700
NCGC00167431-01
NCGC00167431-03
Prifitin
Priftin
Priftin (TN)
Priftin, Cyclopentylrifampicin, Rifapentine
R 77-3
R-773
Retinal pigment epithelium
Rifamycin AF/ACPP
Rifamycin, 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)-
rifamycin, 3-[[(4-cyclopentyl-1-piperazinyl)imino]methyl]-, monohydrochloride
Rifapentin
Rifapentina
Rifapentina [Spanish]
Rifapentine (Priftin)
Rifapentine (USAN/INN)
Rifapentine [USAN:BAN:INN]
Rifapentine [USAN:INN:BAN]
Rifapentine, Antibiotic for Culture Media Use Only
Rifapentinum
Rifapentinum [Latin]
RISDZDVHYCURHD-QLWTZYDESA-N
RPE
RPT
s1760
SAM001246620
SAM002589953
SC-81072
SCHEMBL41590
SCHEMBL41591
SMR000466332
Tox21_112435
UNII-XJM390A33U
W-105162
XJM390A33U
ZINC169292535
ZINC169621228
ZINC306122936
ZINC585656250

US Patents and Regulatory Information for rifapentine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us PRIFTIN rifapentine TABLET;ORAL 021024-001 Jun 22, 1998 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Julphar
Merck
Mallinckrodt
Cipla
Queensland Health
Daiichi Sankyo
Harvard Business School
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.